Smart for Life (SMFL) Featured by New to the Street

Interviews to Air on National Television Including Bloomberg and Fox Business MIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Smart...

Adding Silo Pharma (SILO) $3.50 to Watch List.

Look What We Found! We launched the Psychedelic Stock Review a little more than a year ago and decided...

Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.

Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split...

Adding Unicycive (UNCY) $0.75 to the Watch List.

Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is...

Ouch, for Now. Progressive Care Does 200:1 Reverse.

MASSIVE REVERSE SPLIT Let's just watch from the sidelines for...

He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!

Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
SILO Pharmaceutical, Psychedelic Stock Review

Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis

SPU-21 effective in controlling arthritis progression. SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide

Ardelyx (ARDX). Don’t be Nervous, It’s Just Money.

The Higher it Goes, The More Nervous we Get. LIVE QUOTE

FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.

Oh boy, another day, another snag. There goes our Christmas bonus, dang. LIVE QUOTE It's been...

Doubling Down After ATAI’s (ATAI) Anti Depression Treatment Bombs in Front of FDA.

Both a bad day and a Good day for Psychedelics. The Psychedelic Sector Holds Firm. Atai was founded in...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...